Patent · US Active

Anti-indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereof

US10436785B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

Spring BioScience Corporation · US

Inventors

Fernando Jose Rebelo do Couto · Pleasanton, US
Zhiming Liao · Livermore, US
Yifei Zhu · Alpharetta, US

Key dates

Filing date	Nov 29, 2016
Grant date	Oct 8, 2019
Priority date	—
Expiry date	Jul 17, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/90241
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention provides antibodies that bind specifically to human indoleamine 2,3-dioxygenase 1 (IDO1), and methods of using the same. The antibodies are capable of binding to a sequence comprising SEQ ID NO: 1 and specifically bind to human IDO1 in formalin fixed paraffin embedded tissues. The antibodies are useful in a number of different analytical techniques, including immunohistochemistry (IHC) and immunocytochemistry (ICC).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.